Market Value139,969,967
Total Holdings35
File Date2026-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AXSM / Axsome Therapeutics, Inc.
URGN / UroGen Pharma Ltd.
CGEM / Cullinan Therapeutics, Inc.
MPLT / MapLight Therapeutics, Inc.
SION / Sionna Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
MNMD / Mind Medicine (MindMed) Inc.
CDTX / Cidara Therapeutics, Inc.
ENTX / Entera Bio Ltd.
RZLT / Rezolute, Inc.
SPRB / Spruce Biosciences, Inc.
AARD / Aardvark Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
ASMB / Assembly Biosciences, Inc.
AVTX / Avalo Therapeutics, Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
DNTH / Dianthus Therapeutics, Inc.
TRVI / Trevi Therapeutics, Inc.
ANL / Adlai Nortye Ltd. - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
IPSC / Century Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
DRUG / Bright Minds Biosciences Inc.
DFTX / Definium Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
CLYM / Climb Bio, Inc.
ARVN / Arvinas, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
CLDX / Celldex Therapeutics, Inc.
SMMT / Summit Therapeutics Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
UTHR / United Therapeutics Corporation
COGT / Cogent Biosciences, Inc.
TSHA / Taysha Gene Therapies, Inc.
VIR / Vir Biotechnology, Inc.
TVTX / Travere Therapeutics, Inc.
IMVT / Immunovant, Inc.
TARA / Protara Therapeutics, Inc.
PFE / Pfizer Inc.
BMEA / Biomea Fusion, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
IQV / IQVIA Holdings Inc.
SVRA / Savara Inc.
DVAX / Dynavax Technologies Corporation
FULC / Fulcrum Therapeutics, Inc.
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
PALI / Palisade Bio, Inc.
PVLA / Palvella Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
TERN / Terns Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
VRDN / Viridian Therapeutics, Inc.
QNCX / Quince Therapeutics, Inc.
ZBIO / Zenas BioPharma, Inc.
CAPR / Capricor Therapeutics, Inc.
PTN / Palatin Technologies, Inc.
ORKA / Oruka Therapeutics, Inc.